- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles
- Instablogs1 new
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ZLCS Market Currents
more »
ZLCS in Focus
more »
ZLCS Related Articles
more »
ZLCS News
more »
-
at MarketWatch.com (Jul 7, 2011)
-
at MarketWatch.com (Jul 5, 2011)
-
at MarketWatch.com (Jul 5, 2011)
-
at MarketWatch.com (Apr 21, 2011)
-
at MarketWatch.com (Jan 5, 2011)
ZLCS Press Releases and Filings
more »
-
Business Wire (May 9, 2012)
-
Business Wire (May 3, 2012)
-
Business Wire (May 2, 2012)
-
Business Wire (Apr 30, 2012)
-
Business Wire (Apr 26, 2012)
ZLCS Latest Transcript
more »
-
Thu, Mar 25, 2010Popular searches: acquisition, cash, fourth, pipeline, Crxx, combinatorx, december, development, thank, drug.
ZLCS Cramer
more »
Currently, there are no Cramer articles on ZLCS.
ZLCS Instablog posts
more »
ZLCS vs. ETF Alternatives
Company Description
We are a biopharmaceutical company pioneering the field of synergistic combination pharmaceuticals. Going beyond traditional combinations, we use our innovative drug discovery technology to create product candidates with novel multi-target mechanisms of action striking at the biological... More
